Gamble Jones Investment Counsel Eli Lilly & CO Transaction History

Gamble Jones Investment Counsel

$1.33 Billion
Q4 2022

A detailed history of Gamble Jones Investment Counsel transactions in Eli Lilly & CO stock. As of the latest transaction made, Gamble Jones Investment Counsel holds 12,050 shares of LLY stock, worth $9.58 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares

12,050

Previous 12,210 1.31%

Holding current value

$9.58 Million

Previous $3.95 Million 11.65%

% of portfolio

0.33%

Previous 0.32%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$321.55 - $374.67 $51,448 - $59,947	-160 Reduced 1.31%	12,050 $4.41 Million
Q2 2022 Aug 05, 2022	SELL	$278.73 - $327.27 $264,793 - $310,906	-950 Reduced 7.22%	12,210 $3.96 Million
Q1 2022 May 02, 2022	SELL	$234.69 - $291.66 $5,867 - $7,291	-25 Reduced 0.19%	13,160 $3.77 Million
Q4 2021 Feb 09, 2022	SELL	$224.85 - $279.04 $8,769 - $10,882	-39 Reduced 0.29%	13,185 $3.64 Million
Q3 2021 Nov 09, 2021	SELL	$221.6 - $272.71 $106,811 - $131,446	-482 Reduced 3.52%	13,224 $3.06 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $798,031 - $1.03 Million	4,420 Added 47.6%	13,706 $3.15 Million
Q1 2021 May 10, 2021	SELL	$164.32 - $212.72 $82,324 - $106,572	-501 Reduced 5.12%	9,286 $1.74 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $55,054 - $72,849	-422 Reduced 4.13%	9,787 $1.65 Million
Q3 2020 Nov 10, 2020	SELL	$146.22 - $169.13 $76,619 - $88,624	-524 Reduced 4.88%	10,209 $1.51 Million
Q2 2020 Aug 19, 2020	SELL	$136.42 - $164.18 $40,925 - $49,254	-300 Reduced 2.72%	10,733 $1.76 Million
Q1 2020 May 08, 2020	SELL	$119.05 - $147.35 $213,099 - $263,756	-1,790 Reduced 13.96%	11,033 $1.53 Million
Q4 2019 Feb 10, 2020	SELL	$106.92 - $132.43 $99,007 - $122,630	-926 Reduced 6.74%	12,823 $1.69 Million
Q3 2019 Nov 04, 2019	SELL	$106.79 - $116.16 $16,018 - $17,424	-150 Reduced 1.08%	13,749 $1.54 Million
Q2 2019 Aug 20, 2019	SELL	$110.79 - $129.32 $132,948 - $155,184	-1,200 Reduced 7.95%	13,899 $1.54 Million
Q1 2019 May 02, 2019	SELL	$111.31 - $131.02 $16,696 - $19,653	-150 Reduced 0.98%	15,099 $1.96 Million
Q4 2018 Feb 04, 2019	SELL	$105.9 - $118.64 $92,133 - $103,216	-870 Reduced 5.4%	15,249 $1.77 Million
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $25,758 - $32,193	-300 Reduced 1.83%	16,119 $1.73 Million
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $22,710 - $26,064	-300 Reduced 1.79%	16,419 $1.4 Million
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $25,811 - $27,685	-315 Reduced 1.85%	16,719 $1.41 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $1.31 Million - $1.46 Million	17,034	17,034 $1.46 Million

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamble Jones Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Gamble Jones Investment Counsel with notifications on news.

Account

Gamble Jones Investment Counsel Eli Lilly & CO Transaction History